(469) 485-2382 / Toll-Free (888) 509-5227 info@mcidiagnostics.com

Soluble Liver Ag (IgG Ab)

Test ID: 


CPT code:



Soluble Liver Antigen (SLA) IgG Antibody

SLA, IgG Antibody

Clinical Use:

Aid in the diagnosis of autoimmune hepatitis (AIH)

Test Information:

Autoimmune hepatitis (AIH) is a chronic, progressive, heterogeneous inflammatory liver disease of unknown etiology. Diagnosis is often difficult since there is no single diagnostic test for AIH and presenting symptoms can be quite varied. Diagnosis includes evaluation of clinical laboratory and histological findings as well as the exclusion of other causes of chronic hepatitis. Diagnosis is particularly difficult with patients classified with cryptogenic hepatitis, described as having an undefined chronic hepatitis without antibodies to viral or the conventional profile of autoimmune markers. Early diagnosis of AIH and immunosuppressive treatment are essential to help prevent severe liver damage
AIH patients are generally divided into two groups based on the presence of specific autoantibodies. AIH type 1 (also referred to as classic, active chronic, lupoid, plasma cell, or autoimmune chronic active hepatitis) is the more common type of AIH. AIH-1 is characterized by antinuclear, antismooth muscle (directed against both antiactin and nonactin components), and perinuclear and antineutrophil cytoplasmic antibodies. Liver/kidney microsome antibodies and antiliver cytosol antigen (LC-1) characterize AIH type 2
Autoantibodies against soluble liver antigen (anti-SLA) show a high specificity (approximately 99%) for AIH; however, they are detectable in only 10% to 30% of patients with AIH. SLA is a 50 kilodalton cytosolic protein that is thought to be involved in the selenocysteine pathway. Anti-SLA and the independently described anti-LP are identical. The findings of anti-SLA has been associated with an increased prevalence of the HLA-DR3 genotype and a decreased prevalence of the HLA-DR4 genotype. Anti-SLA positive patients have a higher rate of relapse after corticosteroid than seronegative patients. Recent studies have suggested that patients with anti-SLA/LP have a more severe course of autoimmune hepatitis, although the exact function and role of this autoantibody remain unclear.

Specimen Type:


Requested Volume: 

0.6 mL

Minimum Volume: 

0.3 mL

Container Type: 

Red-top tube or gel-barrier tube


If a red-top tube is used, transfer separated serum to a plastic transport tube.

Storage Instructions:


Rejection Criteria

Nonserum specimen received; specimen in azide or other preservative; microbially-contaminated specimen; heat-treated specimen; gross lipemia or hemolysis

Return Back to Test Directory

MCI Diagnostic

Providing top patient care with fast results. 

Hours of Operation

Mon - Sat: 7 AM-11 PM

Sun: 7 AM-3 PM

COVID-19 Drive-Thru Hours

Mon-Fri: 9 AM-6 PM

Federal Holidays - CLOSED

More Information - Click Here

Government Contract

DUNS # 125722608

Cage Code: 3FPQ3


COVID-19 Fee & Pricing